Key terms

About CNC

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CNC news

Yesterday 10:37am ET Centene rises, Molina slides following Florida’s managed Medicaid awards Yesterday 9:56am ET Early notable gainers among liquid option names on April 15th Yesterday 9:47am ET Centene rises 5.3% Yesterday 6:16am ET Molina Healthcare price target lowered to $410 from $440 at Wells Fargo Yesterday 6:15am ET Centene price target raised to $93 from $89 at Wells Fargo Yesterday 6:10am ET Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Ultragenyx Pharmaceutical (RARE) Apr 08 6:22am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Apr 04 6:31am ET Thursday Macro & Markets Update – 04.04.24 Mar 29 11:12am ET Centene Announces James E. Murray’s Retirement for 2024 Mar 26 12:15am ET Centene (CNC) was downgraded to a Hold Rating at Stephens Mar 21 9:49am ET Microsoft initiated, Broadcom upgraded: Wall Street’s top analyst calls Mar 21 6:26am ET Centene downgraded to Equal Weight from Overweight at Stephens Mar 11 4:43pm ET Centene to Reaffirm 2024 Earnings Guidance at Barclays Conference Mar 06 6:35am ET Barclays starts health care facilities, managed care group with Neutral view Mar 05 4:28pm ET Centene initiated with an Overweight at Barclays Mar 04 7:02pm ET Bernstein Reaffirms Their Buy Rating on Centene (CNC) Mar 01 8:35am ET Buy Rating on Centene (CNC) Stock: Optimistic Outlook Based on Medicaid Prospects, HIX Growth, and Conservative Guidance Feb 21 5:32pm ET Centene files automatic mixed securities shelf Feb 12 6:15am ET Buy Rating on Centene (CNC) with Increased Price Target Amid Positive Financial Projections and Market Share Stability Feb 07 10:27am ET Centene (CNC) Holds Steady: Balancing Earnings Resilience and Market Risks in Q4:23 Summary Feb 07 9:02am ET Centene price target lowered to $81 from $82 at Deutsche Bank Feb 07 8:16am ET Centene Buy Rating Affirmed: Clear Growth Trajectory and Margin Expansion Potential Feb 07 8:02am ET Analysts’ Top Healthcare Picks: Rallybio (RLYB), Madrigal Pharmaceuticals (MDGL) Feb 07 6:00am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elanco Animal Health (ELAN), Hologic (HOLX) and Centene (CNC) Feb 07 5:29am ET Buy Rating on Centene’s Stock Backed by Strong Performance and Positive Projections Feb 06 6:45pm ET Goldman Sachs Keeps Their Hold Rating on Centene (CNC) Feb 06 6:09am ET Centene reports Q4 EPS 45c, consensus 43c Feb 05 8:25pm ET Notable companies reporting before tomorrow’s open Feb 05 1:02pm ET Notable companies reporting before tomorrow’s open Jan 22 7:30am ET Centene appoints Michael Carson as CEO of Medicare business Jan 18 4:40pm ET Centene subsidiary selected by New Hampshire DHHS

No recent news articles are available for CNC

No recent press releases are available for CNC

CNC Financials

1-year income & revenue

Key terms

CNC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CNC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms